Jordi Ribera

803 total citations
16 papers, 464 citations indexed

About

Jordi Ribera is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Jordi Ribera has authored 16 papers receiving a total of 464 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Hepatology, 6 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Jordi Ribera's work include Liver Disease Diagnosis and Treatment (6 papers), Liver physiology and pathology (5 papers) and Liver Disease and Transplantation (5 papers). Jordi Ribera is often cited by papers focused on Liver Disease Diagnosis and Treatment (6 papers), Liver physiology and pathology (5 papers) and Liver Disease and Transplantation (5 papers). Jordi Ribera collaborates with scholars based in Spain, United States and China. Jordi Ribera's co-authors include Wladimiro Jiménez, Manuel Morales‐Ruiz, Pedro Melgar‐Lesmes, Montse Pauta, Guillermo Fernández‐Varo, Gregori Casals, Víctor Puntes, Eudald Casals, Denise Oró and Marina Parra‐Robert and has published in prestigious journals such as SHILAP Revista de lepidopterología, Nano Letters and ACS Nano.

In The Last Decade

Jordi Ribera

16 papers receiving 457 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jordi Ribera Spain 11 182 160 113 104 98 16 464
Vedrana Reichenbach Spain 11 144 0.8× 137 0.9× 72 0.6× 95 0.9× 133 1.4× 15 481
Vaishaali Natarajan United States 7 110 0.6× 63 0.4× 138 1.2× 86 0.8× 108 1.1× 8 421
Ji-Yeon Seo South Korea 11 43 0.2× 64 0.4× 223 2.0× 42 0.4× 48 0.5× 13 489
Jiawei Cao China 13 173 1.0× 177 1.1× 45 0.4× 69 0.7× 70 0.7× 18 383
Fen Zhang China 12 68 0.4× 74 0.5× 134 1.2× 16 0.2× 84 0.9× 21 389
Kelly Koral United States 10 47 0.3× 70 0.4× 109 1.0× 11 0.1× 52 0.5× 15 325
Eloïse Woitrain France 8 42 0.2× 139 0.9× 167 1.5× 24 0.2× 63 0.6× 15 384
Xufeng Lu China 8 45 0.2× 39 0.2× 151 1.3× 34 0.3× 41 0.4× 15 329
Sayuri Nakamura Japan 11 55 0.3× 103 0.6× 79 0.7× 16 0.2× 49 0.5× 39 408

Countries citing papers authored by Jordi Ribera

Since Specialization
Citations

This map shows the geographic impact of Jordi Ribera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jordi Ribera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jordi Ribera more than expected).

Fields of papers citing papers by Jordi Ribera

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jordi Ribera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jordi Ribera. The network helps show where Jordi Ribera may publish in the future.

Co-authorship network of co-authors of Jordi Ribera

This figure shows the co-authorship network connecting the top 25 collaborators of Jordi Ribera. A scholar is included among the top collaborators of Jordi Ribera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jordi Ribera. Jordi Ribera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Ribera, Jordi, Montse Pauta, Gregori Casals, et al.. (2023). Liver FoxO1 overexpression is positively associated with the degree of liver injury in cirrhotic patients. SHILAP Revista de lepidopterología. 4(3). 218–226. 2 indexed citations
2.
Ribera, Jordi, Juan Rodríguez‐Vita, Gregori Casals, et al.. (2021). The loss of DHX15 impairs endothelial energy metabolism, lymphatic drainage and tumor metastasis in mice. Communications Biology. 4(1). 1192–1192. 6 indexed citations
3.
Ribera, Jordi, Clara Vilches, Vanesa Sanz, et al.. (2021). Treatment of Hepatic Fibrosis in Mice Based on Targeted Plasmonic Hyperthermia. ACS Nano. 15(4). 7547–7562. 36 indexed citations
4.
Carvajal, Silvia, Meritxell Perramón, Denise Oró, et al.. (2019). Cerium oxide nanoparticles display antilipogenic effect in rats with non-alcoholic fatty liver disease. Scientific Reports. 9(1). 12848–12848. 40 indexed citations
5.
Ribera, Jordi, Juan Rodríguez‐Vita, Gregori Casals, et al.. (2019). Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats. PLoS ONE. 14(6). e0218716–e0218716. 23 indexed citations
6.
Ribera, Jordi, Montse Pauta, Denise Oró, et al.. (2019). Cerium oxide nanoparticles improve liver regeneration after acetaminophen-induced liver injury and partial hepatectomy in rats. Journal of Nanobiotechnology. 17(1). 112–112. 58 indexed citations
7.
Ribera, Jordi, et al.. (2019). The Role of Hepatic and Splanchnic Lymphatic System in Portal Hypertension and Ascites. Current Hepatology Reports. 18(2). 157–163. 5 indexed citations
8.
Carvajal, Silvia, Meritxell Perramón, Gregori Casals, et al.. (2019). Cerium Oxide Nanoparticles Protect against Oxidant Injury and Interfere with Oxidative Mediated Kinase Signaling in Human-Derived Hepatocytes. International Journal of Molecular Sciences. 20(23). 5959–5959. 34 indexed citations
9.
Perissinotti, Andrés, Sergi Vidal‐Sicart, Jordi Pérez, et al.. (2019). 99mTc-Tilmanocept. First experiences and practical approach in melanoma sentinel node biopsy in a two-day protocol.. 60. 1269–1269. 1 indexed citations
10.
Melgar‐Lesmes, Pedro, et al.. (2018). Graphene–Dendrimer Nanostars for Targeted Macrophage Overexpression of Metalloproteinase 9 and Hepatic Fibrosis Precision Therapy. Nano Letters. 18(9). 5839–5845. 48 indexed citations
11.
Ribera, Jordi, Montse Pauta, Pedro Melgar‐Lesmes, et al.. (2017). A small population of liver endothelial cells undergoes endothelial-to-mesenchymal transition in response to chronic liver injury. American Journal of Physiology-Gastrointestinal and Liver Physiology. 313(5). G492–G504. 53 indexed citations
12.
Santel, Ansgar, Jordi Ribera, Wladimiro Jiménez, & Manuel Morales‐Ruiz. (2017). The Role of Akt in Chronic Liver Disease and Liver Regeneration. Seminars in Liver Disease. 37(1). 11–16. 29 indexed citations
13.
Morales‐Ruiz, Manuel, et al.. (2016). Sipa1l1 is an early biomarker of liver fibrosis in CCl4-treated rats. Biology Open. 5(6). 858–865. 6 indexed citations
14.
Pauta, Montse, Noemí Rotllán, Cédric Langhi, et al.. (2015). Akt‐mediated foxo1 inhibition is required for liver regeneration. Hepatology. 63(5). 1660–1674. 52 indexed citations
15.
Pauta, Montse, Jordi Ribera, Pedro Melgar‐Lesmes, et al.. (2014). Overexpression of angiopoietin‐2 in rats and patients with liver fibrosis. Therapeutic consequences of its inhibition. Liver International. 35(4). 1383–1392. 30 indexed citations
16.
Ribera, Jordi, Montse Pauta, Pedro Melgar‐Lesmes, et al.. (2012). Increased nitric oxide production in lymphatic endothelial cells causes impairment of lymphatic drainage in cirrhotic rats. Gut. 62(1). 138–145. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026